A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants

Clinical trial NCT02337751 · COMPLETED

Trial details

NCT number: NCT02337751
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2015-07-10
Primary completion: 2017-03-14
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.